MedPath

the effect cabergoline on reducing pain in endometriosis patients

Phase 3
Recruiting
Conditions
Endometriosis.
Endometriosis
Registration Number
IRCT20181030041503N6
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
72
Inclusion Criteria

Diagnosis of clinical endometriosis by observing pain and tenderness in the pelvic examination along with endometriosis nodules in the vaginal examination, firm and motionless uterus and confirmed by ultrasound or MRI (observation of endometriosis cysts and nodules)
Diagnosis of grade I-IV endometriosis based on r-ASRM criteria during diagnostic laparoscopy during the previous 12 months
Dysmenorrhea complaint with EAPP score >30 or >40
Normal pap smear

Exclusion Criteria

Endometriosis treated less than 6 months ago with a GNRH agonist or less than 3 months ago danazol or progesterone tablets or less than 1 month ago with oral contraceptives.
Breastfeeding
pregnancy
Cancers of the uterus, ovaries, cervix and high-grade intraepithelial lesions

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath